News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Invus Public Equities, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/05/2023 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 27,775,050 shares
@ $2.6, valued at
$72.2M
|
|
| 05/02/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 31,557 shares
@ $6.4279, valued at
$202.8k
|
|
| 02/28/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 100,000 shares
@ $1.7, valued at
$170k
|
|
| 02/23/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 50,000 shares
@ $1.85, valued at
$92.5k
Bought 150,000 shares
@ $1.7933, valued at
$269k
Bought 200,000 shares
@ $1.7538, valued at
$350.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/11/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Sold 1,094 shares
@ $9.482, valued at
$10.4k
|
|
| 01/09/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 48,774 shares
@ $9.3306, valued at
$455.1k
|
|
| 10/27/2022 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 130,265 shares
@ $8.0404, valued at
$1M
|
|
| 10/07/2022 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 33,971 shares
@ $7.0292, valued at
$238.8k
Bought 66,000 shares
@ $7.8903, valued at
$520.8k
|
|
| 08/09/2022 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 2,426,070 shares
@ $2.5, valued at
$6.1M
|
|
| 08/01/2022 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 16,173,800 shares
@ $2.5, valued at
$40.4M
|
|
| 06/24/2022 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Scholar Rock Holding Corp |
| 08/03/2021 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $16.1379, valued at
$1.2M
Converted 1,323,530 shares
@ $0
Bought 875,000 shares
@ $17, valued at
$14.9M
Converted 5,000,000 convertible preferred
@ $0 |
|
| 07/29/2021 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2021 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Seer, Inc.|
Txns:
| Sold 252,545 shares
@ $64.153, valued at
$16.2M
|
|
| 12/17/2020 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 10,937,500 shares
@ $3.2, valued at
$35M
|
|
| 12/10/2020 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Seer, Inc.|
Txns:
| Converted 5,050,911 shares
@ $0
Bought 790,000 shares
@ $19, valued at
$15M
Converted 3,953,381 convertible preferred
@ $0
Converted 373,831 convertible preferred
@ $0
Converted 474,478 convertible preferred
@ $0
Converted 249,221 convertible preferred
@ $0 |
|
| 12/03/2020 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Seer, Inc. |
| 11/13/2020 |
SC 13G
| Invus Public Equities, L.P. reports a 6.5% stake in SQZ Biotechnologies Company |
| 11/03/2020 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Converted 1,141,308 shares
@ $0
Bought 465,000 shares
@ $16, valued at
$7.4M
Converted 843,490 convertible preferred
@ $0
Converted 240,375 convertible preferred
@ $0 |
|
| 10/29/2020 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on SQZ Biotechnologies Co |
| 06/18/2020 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Generation Bio Co.|
Txns:
| Converted 2,014,191 shares
@ $0
Bought 800,000 shares
@ $19, valued at
$15.2M
Converted 2,186,820 preferred shares
@ $0
Converted 1,073,076 preferred shares
@ $0 |
|
| 06/11/2020 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Generation Bio Co. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/29/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 125,114 shares
@ $12.5361, valued at
$1.6M
Bought 57,724 shares
@ $12.4547, valued at
$718.9k
|
|
| 06/26/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 25,461 shares
@ $13.3573, valued at
$340.1k
Bought 228,264 shares
@ $12.9459, valued at
$3M
|
|
| 06/21/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 8,982 shares
@ $13.4512, valued at
$120.8k
Bought 12,391 shares
@ $13.2849, valued at
$164.6k
Bought 51,600 shares
@ $13.2677, valued at
$684.6k
|
|
| 06/18/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 9,200 shares
@ $12.6589, valued at
$116.5k
Bought 36,584 shares
@ $13.0641, valued at
$477.9k
|
|
| 06/12/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 29,747 shares
@ $12.8896, valued at
$383.4k
Bought 98,626 shares
@ $12.7497, valued at
$1.3M
Bought 107,023 shares
@ $12.8313, valued at
$1.4M
|
|
| 06/07/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 173,121 shares
@ $12.4548, valued at
$2.2M
Bought 95,079 shares
@ $12.5829, valued at
$1.2M
Bought 57,439 shares
@ $12.9269, valued at
$742.5k
|
|
| 06/04/2018 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 147,339 shares
@ $11.6198, valued at
$1.7M
Bought 147,339 shares
@ $12.217, valued at
$1.8M
Bought 121,803 shares
@ $12.2376, valued at
$1.5M
|
|
| 05/31/2018 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Converted 1,946,040 shares
@ $0
Bought 450,000 shares
@ $14, valued at
$6.3M
Converted 5,555,556 preferred shares
@ $0 |
|
|
|
|